176045-80-0 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(4-Bromobenzyl)-1-(4-methoxyphenyl)hydrazine is used as a key intermediate in the synthesis of pharmaceuticals for various diseases. Its unique structural features allow it to be a versatile building block in the creation of novel drug candidates with potential therapeutic benefits.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(4-Bromobenzyl)-1-(4-methoxyphenyl)hydrazine serves as a valuable precursor for the synthesis of other biologically active compounds. Its bromobenzyl and methoxyphenyl groups can be further modified or used to construct complex organic molecules with specific biological properties.
Used in Medicinal Chemistry:
1-(4-Bromobenzyl)-1-(4-methoxyphenyl)hydrazine is utilized in medicinal chemistry as a starting material for the design and synthesis of new drugs. Its structural diversity and potential pharmacological activities make it an attractive candidate for the development of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 176045-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,0,4 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 176045-80:
(8*1)+(7*7)+(6*6)+(5*0)+(4*4)+(3*5)+(2*8)+(1*0)=140
140 % 10 = 0
So 176045-80-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H15BrN2O/c1-18-14-8-6-13(7-9-14)17(16)10-11-2-4-12(15)5-3-11/h2-9H,10,16H2,1H3
176045-80-0Relevant articles and documents
COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
-
Page/Page column 95-96, (2008/12/06)
Disclosed herein are compositions and compounds that combine an inhibitor of 5-lipoxygenase activating protein (FLAP) and a modulator of NO levels in a mammal. The NO modulator can be an agent that induces the production of NO in a mammal, or can be an ag
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2-inhibitors
Black,Bayly,Belley,Chan,Charleson,Denis,Gauthier,Gordon,Guay,Kargman,Lau,Leblanc,Mancini,Ouellet,Percival,Roy,Skorey,Tagari,Vickers,et al.
, p. 725 - 730 (2007/10/03)
A series of potent and highly selective cyclooxygenase-2 inhibitors have been prepared by replacing the benzoyl group of indomethacin with a 4-bromobenzyl group, and by extending the acetic acid side chain. These compounds show anti-inflammatory activity in rats with no evidence of GI toxicity, even at high doses.
